Express News Service LUCKNOW: The Central Drug Research Institute (CDRI) has claimed to have developed an indigenous anti-viral drug– Umifenovir—for the treatment of Covid-19....
clinical trial
By ANI NEW DELHI: The Subject Expert Committee (SEC) has recommended Phase 1 clinical trials of Reliance’s recombinant COVID-19 vaccine candidate. Earlier, Mukesh Ambani-owned...
By ANI NEW DELHI: MSN Laboratories Private Limited (MSN) is initiating phase III clinical trial of Molnupiravir capsules for the treatment of COVID-19 in...